Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 9, 2002, Pages 1034-1041

  Kleessen, Brigitta ^a   Kroesen, A J ^a   Buhr, H J ^a   Blaut, M ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Crohn disease; In situ hybridization; Inflammatory bowel disease; Intestinal bacteria; Mucin; Mucosa; Ulcerative colitis

Indexed keywords

MUCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEROIDES; CELL INVASION; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM HISTOLYTICUM; CLOSTRIDIUM LITUSEBURENSE; COLON; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENTEROBACTERIACEAE; EUBACTERIUM; EUBACTERIUM RECTALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; ILEUM; IN SITU HYBRIDIZATION; INTESTINE FLORA; INTESTINE MUCOSA; NONHUMAN; PATHOGENESIS; PREVOTELLA; PRIORITY JOURNAL; SULFATE REDUCING BACTERIUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; COLONY COUNT, MICROBIAL; CROHN DISEASE; DNA, BACTERIAL; HUMANS; ILEUM; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL MUCOSA; MIDDLE AGED; OLIGONUCLEOTIDE PROBES;

EID: 0036741464     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202320378220     Document Type: Article

References (37)

1. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S-11S.
2. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut 2001;48:132-5.
3. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13.
4. Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumonia within inflammatory bowel disease tissues. J Clin Pathol 1998;51:657-61.
5. Tiveljung A, Söderholm JD, Olaison G, Jonasson J, Monstain HJ. Presence of eubacteria in biopsies from Crohn's disease inflammatory lesions as determined by 16S rRNA gene-based PCR. J Med Microbiol 1999;48:263-8.
6. Linskens RK, Huijsdens XW, Savelkoul PHM, Vandenbroucke-Grauls CMJE, Meuwissen SGM. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 2001;36 Suppl 234:29-40.
7. Gibson GR, Cummings JH, Macfarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991;86:103-12.
8. Zinkevich V, Beech IB. Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. FEMS Microbiol Ecol 2000;34:147-55.
9. Roediger WEW, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
10. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000;46:64-72.
11. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997;148:567-76.
12. Sellon RK, Tonkonogy SL, Schultz M, Dieleman LA, Grenther W, Balish E, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
13. 2-microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
14. Allen DC, Connolly NS, Biggart JD. Mucin profiles in ulcerative colitis with dysplasia and carcinoma. Histopathology 1988;13:413-24.
15. McCormick DA, Horton LW, Mee AS. Mucin depletion in inflammatory bowel disease. J Clin Pathol 1990;43:143-6.
16. Pullan RD, Thomas GAO, Rhodes M, Newcombe RG, Williams GT, Allen A, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994;35:353-9.
17. Rhodes JM. Mucins and inflammatory bowel disease. Q J Med 1997;90:79-82.
18. Kleessen B, Noack J, Blaut M. Distribution of viable and non-viable bacteria in the gastrointestinal tract of gnotobiotic and conventional rats. MEHD 1999;11:218-25.
19. Amann RI, Ludwig W, Schleifer K-H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbial Rev 1995;59:143-69.
20. Roller CM, Wagner M, Amann R, Ludwig W, Schleifer K-H. In situ probing of gram-positive bacteria with high DNA G+C content by using 23S rRNA-targeted oligonucleotides. Microbiology 1994;140:2849-58.
21. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer K-H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophagaflavobacter-bacteroides in the natural environment. Microbiology 1996;142:1097-106.
22. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Shut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:3336-45.
23. Langendijk PS, Shut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MHF, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with the genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995;61:3069-75.
24. Harmsen HJM, Elfferich P, Shut F, Welling GW. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. MEHD 1999;11:3-12.
25. Manz W, Amann R, Ludwig W, Wagner M, Schleifer K-H. Phylogenetic oligodeoxynucleotide probes for the major subclasses of proteobacteria: problems and solutions. System Appl Microbiol 1992;15:593-600.
26. Poulsen LK, Licht TR, Rang C, Crogfelt KA, Molin S. Physiological state of E. coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 1995;177:5840-5.
27. Harmsen HJM, Wildeboer-Veloo AC, Grijpstra J, Knol J, Degener JE, Welling GW. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000;66:4523-7.
28. Suau A, Rochet V, Sghir A, Gramet G, Brewaeys S, Sutren M, et al. Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 2001;24:139-45.
29. Manz W, Eisenbrecher M, Neu TR, Szewzyk U. Abundance and spatial organization of gram-negative sulfate-reducing bacteria in activated sludge investigated by in situ probing with specific 16S rRNA targeted oligonucleotides. FEMS Microbiol Ecol 1998;25:43-61.
30. Hristova KR, Mau M, Zheng D, Aminov RI, Mackie RI, Gaskins HR, et al. Desulfotomaculum genus- and subgenus-specific 16S rRNA hybridization probes for environmental studies. Environ Microbiol 2000;2:143-59.
31. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, et al. The phylogeny of the genus Clostridium: proposal of five genera and eleven new species combinations. Int J Syst Bacteriol 1994;44:812-26.
32. Von Wulffen H, Rüssmann H, Karch H, Meyer T, Bitzan M, Kohrt TC, et al. Verocytoxin-producing Escherichia coli O2:H isolated from patients with ulcerative colitis. Lancet 1989;1:1449-50.
33. Schultsz C, Moussa M, Van Ketel RJ, Tytgat GNJ, Dankert J. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 1997;50:573-9.
34. Schultsz C, Van den Berg FM, Ten Kate FW, Tytgat GNJ, Dankert J. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 1999;117:1089-97.
35. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
36. Macfarlane S, Cummings JH, Macfarlane GT. Bacterial populations on the rectal mucosa in healthy and colitic subjects (Abstract). Gastroenterology 2000;118 Suppl 2: A101,678.
37. Macfarlane S, Hopkins MJ, Macfarlane GT. Bacterial growth and metabolism on surfaces in the large intestine. MEHD 2000;12 Suppl 2:64-72.